Sight Sciences, Inc.

NASDAQ:SGHT

Medical - Devices

Healthcare
$10.77 +2.89%

+$0.15 today

Market cap
$598.59M
Beta
2.40
P/E (TTM)
-7.5
EPS (TTM)
-$0.69
52W Low $3.11High $9.24

Volume 0.34M

Average 0.25M

SGHT Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Sight Sciences, Inc.NASDAQ: SGHT

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash dips below year-ago levels

Q1 FY2026 net change in cash of $7M (cash outflow) fell 39.6% year over year, behind the +27.1% change in trailing-twelve-month net change in cash. Sequentially, it rose 1624.9% from the prior quarter. Over 3 fiscal years it compounded at -28.1% a year.

Context

  • Net change in cash amounted to 36.4% of revenue in FY2025, up 14.1 pp from a year earlier.
  • Net change in cash grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -39.6% toward the trailing-twelve-month pace of +27.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$7M+1624.9% QoQ
Last fiscal yearDec 2025
-$28.13M+58.3% YoY
LTMMar 2026
-$23.54M+27.1% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-39.6%——
1 year+58.3%——
3-year CAGR-28.1%——
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(28.13M) USD
Year-over-year change
-58.3%

Net Change in Cash vs competitors

How SGHT compares with its peers on the latest reported figures

  • SGHT's LTM Mar 2026 net change in cash of $23.54M is the 6th largest of the 7 companies compared; the peer median is $86.99M.
  • Its year-over-year change of +27.1% is the 4th highest of 6, against a peer median of +337.7%.
  • Net change in cash amounts to 29.6% of revenue for SGHT, versus a peer median of 2.1%.
SGHT Competitors Peer median
Net Change in Cash for SGHT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OCULOcular Therapeutix, Inc.LTM Mar 2026$317.02M +337.7%—609.2%
ALCAlcon Inc.LTM Sep 2026$216.6M +406.6%-37.0%2.0%
BHCBausch Health Companies Inc.LTM Jun 2026$93.89M -91.6%—0.9%
SGPSpyGlass Pharma, Inc. Common StockFY2025$80.09M ———
HROWHarrow Health, Inc.LTM Mar 2026$27.92M +1640.7%-22.0%10.4%
SGHTSight Sciences, Inc.LTM Mar 2026$23.54M +27.1%-28.1%29.6%
GKOSGlaukos CorporationLTM Jun 2026$12.92M -59.4%—2.1%
Peer median (excluding SGHT) $86.99M+337.7%-29.5%2.1%

Competitors are the stored peer set for SGHT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(62.96M)(86.24M)(55.55M)(51.51M)(38.43M)
Depreciation & Amortization632K710K614K712K487K
Deferred Income Tax7.76M0000
Stock-Based Compensation5.08M12.96M14.58M17.08M13.05M
Change in Working Capital(4.33M)(5.7M)(9.13M)9M(6.4M)
Accounts Receivables(3.69M)(6.84M)661K3.55M912K
Inventory(1.31M)(3.25M)(2.16M)1.63M(1.44M)
Accounts Payables1.17M(694K)(883K)336K(348K)
Other Working Capital(486K)5.09M(6.76M)3.49M(5.52M)
Other Non-Cash Items1.27M2.3M2.3M2.37M1.59M
Operating Cash Flow(52.54M)(75.97M)(47.18M)(22.35M)(29.69M)
Capital Expenditures(813K)(970K)(791K)(385K)(224K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(813K)(970K)(791K)(385K)(224K)
Debt Repayment0004.15M0
Common Stock Issued256.68M1.25M1.33M1.07M1.85M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(4.15M)1.25M(224K)(261K)(58K)
Financing Cash Flow252.53M1.25M1.1M4.96M1.79M
Effect of Forex Changes00000
Net Change in Cash199.18M(75.69M)(46.87M)(17.77M)(28.13M)
Free Cash Flow(53.35M)(76.94M)(47.98M)(22.74M)(29.92M)

Sight Sciences, Inc.

NASDAQ:SGHT

Intrinsic Alpha fair value

Locked

Current Price

$10.77

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.